Progress of in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitution

BACKGROUND: Continuous infusion of factor VIII (FVIII) is a more cost-effective method for treating hemophilia A than intermittent bolus injection. However, there is currently no specific data in Korea about the progress of in vitro FVIII coagulant activity (FVIII:C) after reconstitution from its ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Ye Jee, Lee, Kun Soo, Kim, Uk Hyun, Suh, Jin Kyung, Baik, Sae Yun, Hyun, Shin Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278009/
https://www.ncbi.nlm.nih.gov/pubmed/25548761
http://dx.doi.org/10.5045/br.2014.49.4.265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278009/
https://www.ncbi.nlm.nih.gov/pubmed/25548761
http://dx.doi.org/10.5045/br.2014.49.4.265

Ejemplares similares